Overview and Scope
Chronic cough refers to a cough that is persistent and lasts for a long time, usually eight weeks or more. It frequently manifests as signs of an underlying illness, such as asthma, allergies, or respiratory infections.
Sizing and Forecast
The chronic cough market size has grown strongly in recent years. It will grow from $7.5 billion in 2023 to $8.16 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to prevalence of underlying respiratory conditions, environmental factors and air pollution, smoking and tobacco use, respiratory infections, allergies and environmental sensitivities.
The chronic cough market size is expected to see strong growth in the next few years. It will grow to $11.48 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to emerging therapies targeting specific pathways, increasing understanding of reflux-related cough, global efforts in smoking cessation, environmental and occupational health policies. Major trends in the forecast period include advancements in diagnostic technologies, patient-centric approaches, therapeutic innovations in neurogenic cough, telehealth for chronic cough management, research on central sensitization.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
Segmentation & Regional Insights
The chronic cough market covered in this report is segmented –
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
North America was the largest region in the chronic cough market in 2023. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12109&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of cough is expected to propel the growth of the chronic cough market going forward. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough. For instance, in March 2022, according to the Florida Health, a US-based Department of Healthcare, in the US total of 80 patients were found in 2021, for incidences of 41.0 and 1.4 per 100,000 years, respectively. There were 28 pertussis cases recorded in 2023 among 13 countries. Furthermore, in March 2022, according to the Statens Serum Institut, a Denmark-based department of disease surveillance, the number of pertussis cases recorded increased by 41% from November 2022 to April 2023, compared to November 2021-April 2022 in Denmark. Therefore, the rise in the prevalence of cough is driving the growth of the chronic cough market.
Key Industry Players
Major companies operating in the chronic cough market report are Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Glaxo SmithKline PLC, Merck KGaA, Reckitt Benckiser Group PLC, Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.
The chronic cough market report table of contents includes:
1. Executive Summary
2. Chronic Cough Market Characteristics
3. Chronic Cough Market Trends And Strategies
4. Chronic Cough Market – Macro Economic Scenario
5. Global Chronic Cough Market Size and Growth
.
.
.
31. Chronic Cough Market Other Major And Innovative Companies
32. Global Chronic Cough Market Competitive Benchmarking
33. Global Chronic Cough Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Chronic Cough Market
35. Chronic Cough Market Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Menopausal hot flashes, also known as vasomotor symptoms, are common menopausal and…
Overview and Scope The lower respiratory tract refers to the portion of the respiratory system…
Overview and Scope Axial Spondyloarthritis (axSpA) is a chronic inflammatory condition that predominantly impacts the…
Overview and Scope Accounting and budgeting software refers to computer programs or applications designed to…
Overview and Scope Serum-free media is a type of cell culture media that allows cells…
Overview and Scope Population screening is a process of assessing the prevalence of a particular…